publication banner


  • Muñoz-Fontela C, Villar LM, Hernandez F, Gallego P, Rodriguez E, Arroyo J, Gao S-J, Avila J, Rivas M. Induction of paclitaxel resistance by the KSHV latent protein LANA2. Journal of Virology, in press.
  • Xie JP, Ajibade AO, Ye FC, Kuhne K and Gao S-J. MEK/ERK, JNK and p38 multiple mitogen-activated protein kinase pathways are essential for the reactivation of Kaposi’s sarcoma-associated herpesvirus from latency. Virology, 2007 Oct 25; [Epub ahead of print].
  • Cloutier N, Eyll OV, Lefort S, Janelle M-E, Gao S-J, Flamand L. Development of a mouse model for the identification of HHV-8 genes contributing to tumorigenesis. Archives of Virology. 2007 Oct 18; [Epub ahead of print].
  • Nun T, Kroll DJ, Oberlies NH, Soejarto DD, Case R, Piskaut P, Matainaho T, Hilscher C, Wang L, Dittmer DP, Gao S-J and Damania B. Development of a fluorescence-based assay to screen antiviral drugs against Kaposi’s sarcoma-associated herpesvirus. Molecular Cancer Therapeutics, 2007, 6, 2360-2370.
  • Qian LW, Xie JP, Ye FC and Gao S-J. Kaposi’s sarcoma-associated herpesvirus infection promotes invasion of primary human umbilical vein endothelial cells by inducing matrix metalloproteinases. Journal of Virology, 2007, 81, 7001-7010.
  • Greene W, Kuhne K, Ye FC, Chen JG, Zhou FC, Lei XF, and Gao S-J. Molecular biology of KSHV in relation to AIDS-associated oncogenesis. In: AIDS-Associated Viral Oncogenesis. 2007, pp: 69-127. Craig Meyers (Ed.). Springer Science+Business Media.
  • Mutlu AD, Cavallin LE, Vincent L, Chiozzini C, Eroles P, Asgari Z, Hooper AT, La Perle KMD, Hilsher C, Gao S-J, Dittmer D, Rafii S and Mesri EA. In vivo-restricted and reversible malignancy induced by human herpesvirus-8 KSHV: a cell and animal model of virally induced Kaposi's sarcoma. Cancer Cell, 2007, 11, 245-258.
  • Ye FC, Blackbourn DJ, Mengel M, Xie JP, Qian LW, Greene W, Yeh I-T, Graham D, and Gao S-J. Kaposi’s sarcoma-associated herpesvirus promotes angiogenesis by inducing angiopoietin-2 expression via AP-1 and Ets1. Journal of Virology, 2007, 81, 3980-3991.
  • Majerciak M, Pripuzova N, McCoy JP, Gao S-J and Zheng Z-M. Targeted disruption of KSHV ORF57 in the viral genome is detrimental for the expression of ORF59, K8, and K8.1 and the production of infectious virus. Journal of Virology, 2007, 81, 1062-1071.
  • Zhu FX, Li XJ, Zhou FC, Gao S-J and Yan Yuan. Functional characterization of Kaposi’s sarcoma-associated herpesvirus ORF45 by BAC-based mutagenesis. Journal of Virology, 2006, 80, 12187-12196.
  • Nair P, Pan HY, Stallings RL and Gao S-J. Recurrent genomic imbalances in primary effusion lymphomas. Cancer Genetics and Cytogenetics. 2006, 171, 119-121.
  • Pan HY, Xie JP, Ye FC, and Gao S-J. Modulation of KSHV infection and replication by MEK/ERK, JNK and p38 multiple mitogen-activated protein kinase pathways during primary infection. Journal of Virology, 2006, 80, 5371-5382.
  • Lu F, Day L, Gao S-J, and Lieberman PM. Acetylation of the latency-associated nuclear antigen regulates repression of Kaposi’s sarcoma-associated herpesvirus lytic transcription. Journal of Virology, 2006, 80, 5273-5282.
  • Fang Q, Liu J, Bai ZQ, Kang T, He ZH, Hu ZH, Gao SJ. KSHV seroprevalence in the general population of Hubei in China. Virologica Sinica, 2006, 21, 97-101.
  • Xie JP, Pan HY, Yoo SM and Gao S-J. Induction of AP-1 and interleukin 6 during KSHV primary infection mediated by multiple MAPK pathways. Journal of Virology, 2005, 79, 15027-15037.
  • Yoo SM, Zhou FC, Ye FC, Pan HY and Gao S-J. Early and sustained expression of latent and host modulating genes in coordinated transcriptional program of KSHV productive primary infection of human primary endothelial cells. Virology, 2005, 343, 47-64.
  • Krishnan HH, Sharma-Wali N, Zeng L, Gao S-J and Chandran B. Envelope glycoprotein B of Kaposi’s sarcoma-associated herpesvirus (KSHV) is essential for egress from infected cells. Journal of Virology, 2005, 79, 10952-10967.
  • Si MW, Jagirdar J, Zhang YJ, Gao S-J, and Yeh TI. Detection of KSHV in transbronchial biopsies in patients with Kaposi’s sarcoma. Applied Immunohistochemistry and Molecular Morphology, 2005, 13, 61-65.
  • Deng JH, Zhang YJ, Wang XP and Gao S-J. Lytic replication-defective Kaposi's sarcoma-associated herpesvirus (KSHV): potential role in infection and malignant transformation. Journal of Virology, 2004, 78, 11108-11120.
  • Pan H-Y, Zhou FC, Gao S-J. KSHV infection induces abnormal centrosome duplication and chromosome instability. Cancer Research, 2004, 64, 4064-4068.
  • Ye FC, Zhou FC, Yoo SM, Xie JP and Gao S-J. Disruption of Kaposi’s sarcoma-associated herpesvirus latent nuclear antigen leads to abortive episome persistence. Journal of Virology, 2004, 78, 11121-11129.
  • Luna RE, Zhou FC, Baghian A, Chouljenko V, Forghani V, Gao S-J, Kousoulas KG. Kaposi’s sarcoma-associated herpesvirus glycoprotein K8.1 is dispensable for viral entry and may facilitate virion egress. Journal of Virology, 2004, 78, 6389-6398.
  • Baillargeon J, Pollock BH, Leach CT, and Gao S-J. The association of neoplasms and HIV infection in the correctional setting. International Journal of STD and AIDS, 2004, 15, 348-51.

Research   I   Lab Members
Send comments concerning this website to: wickes@uthscsa.edu
Last Updated 11/19/07

Links provided from UTHSCSA pages to other web sites do not constitute or imply an endorsement of those sites, their content, or products and services associated with those sites. 
© 2007 Department of Microbiology & Immunology